This inventor holds 1 USPTO granted patent. Top assignee: Institute for Antibodies Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Toshio Honda: Innovator in Camel Antibody Libraries
Introduction
Toshio Honda is a prominent inventor based in Ina, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of camel antibody libraries. His innovative work has the potential to advance therapeutic applications and improve antibody production methods.
Latest Patents
Toshio Honda holds a patent titled "Methods of constructing camel antibody libraries." This invention provides camel antibody libraries that maintain in vivo diversity of camelid antibody variable region genes. The in vivo diversity of antibody variable region genes can be accomplished by mixing genes derived from multiple animals or modifying gene amplification conditions. Conventional methods yield only VHHs with limited repertoire diversity. However, Honda's invention offers libraries comprising genes encoding functional VHHs with sufficient repertoire size. These libraries enable the free acquisition of VHHs against arbitrary antigens. VHHs exhibit excellent solubility and stability, demonstrating reactivity that is typically not expected from tetrameric IgGs.
Career Highlights
Toshio Honda is associated with the Institute for Antibodies Co., Ltd., where he continues to innovate in the field of antibody research. His work has garnered attention for its potential applications in various medical and therapeutic contexts.
Collaborations
Some of his notable coworkers include Yasushi Akahori and Yoshikazu Kurosawa. Their collaborative efforts contribute to the advancement of research in antibody technologies.
Conclusion
Toshio Honda's contributions to the field of biotechnology, particularly through his patent on camel antibody libraries, highlight his role as an innovator. His work not only enhances our understanding of antibody diversity but also paves the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile